Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis
Clinical trial NCT01232543 · COMPLETED
Trial details
- NCT number
- NCT01232543
- Sponsor
- Fougera Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-08-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.